Drospirenone vs Clopidogrel: side-by-side comparison
Drospirenone (Progestogen with anti-mineralocorticoid and anti-androgen activity) and Clopidogrel (P2Y12 receptor antagonist (antiplatelet)) belong to different therapeutic classes and are rarely substitutes for each other. The comparison is useful when a single patient is weighing both options for adjacent or overlapping needs.
| Property | Drospirenone | Clopidogrel |
|---|---|---|
| Therapeutic class | Progestogen with anti-mineralocorticoid and anti-androgen activity | P2Y12 receptor antagonist (antiplatelet) |
| CAS | 67392-87-4 | 113665-84-2 |
| ATC | G03AA12 | B01AC04 |
| Molecular weight | 366.49 g/mol | 321.82 g/mol |
| Brands with this active ingredient | 2 | 1 |
What they share
Drospirenone and Clopidogrel share the common regulatory framework for prescription active ingredients, bioequivalence standards for generics, and pharmacist oversight. Beyond that, points in common are limited.
Key differences
Drospirenone acts by a different mechanism than Clopidogrel, with indications that barely overlap. Comparing the two is useful when a clinician has mentioned both in the same context or the patient wants to understand why one was prescribed instead of the other.
Mechanisms compared
Drospirenone: Drospirenone activates progesterone receptors to suppress ovulation and produce the contraceptive effect when combined with an estrogen. Clopidogrel: Clopidogrel itself is inactive; the active metabolite, formed in the liver by CYP2C19 and other cytochromes, irreversibly binds the P2Y12 ADP receptor on platelets.
Indications compared
Drospirenone: Drospirenone in combination with ethinylestradiol is approved as combined oral contraception, treatment of moderate acne in women requesting contraception, and treatment of premenstrual dysphoric disorder. Clopidogrel: Clopidogrel is approved in adults for the prevention of atherothrombotic events after recent acute coronary syndrome, recent ischaemic stroke or established peripheral arterial disease, and in patients with atrial fibril…
Safety profile
Drospirenone: Common adverse effects include menstrual irregularities, breast tenderness, headache, mood changes and nausea, mostly in the first 2–3 cycles. Clopidogrel: The main adverse effect is bleeding, ranging from minor bruising to severe gastrointestinal or intracranial haemorrhage.
Frequently asked questions
Is Drospirenone better than Clopidogrel? ▾
Drospirenone and Clopidogrel are not "better or worse" — they treat different things. The sensible question is which fits your specific need.
Can Drospirenone and Clopidogrel be combined? ▾
Whether they can be combined depends on the indications and the interaction profile of each. If both are in a single prescription, the prescriber has weighed it; in self-medication they should never be combined.
Do they have the same side-effect profile? ▾
No — they belong to different classes and have distinct side-effect profiles. Each has its own prescribing information.
Products with Drospirenone
Products with Clopidogrel
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.